logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Sep 12, 2019

PharmaCyte Biotech Releases Results of Shareholder Meeting and Provides Information on Upcoming Shareholder Update Call

  • Sep 11, 2019

PharmaCyte Biotech Holding Special Shareholder Meeting Today

  • Sep 4, 2019

PharmaCyte Biotech Releases New Video Documentary of Its Pancreatic Cancer Treatment

  • Aug 28, 2019

PharmaCyte Biotech Confirms Dr. Manuel Hidalgo Will Be Principal Investigator for Clinical Trial in Pancreatic Cancer

  • Aug 27, 2019

PharmaCyte Biotech Releases Proxy Statement Related to Special Shareholder Meeting

  • Aug 21, 2019

PharmaCyte Biotech to Hold Special Shareholder Meeting

  • Jul 22, 2019

PharmaCyte Biotech and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes

  • Jul 15, 2019

PharmaCyte Biotech Appoints Cellular Expert to Medical and Scientific Advisory Board

  • Jun 25, 2019

PharmaCyte Biotech Releases New Interviews from Austrianova’s GMP Facility on Company’s Website

  • Jun 10, 2019

PharmaCyte Biotech CEO in Thailand to Oversee Production of Final Clinical Trial Material for IND Submission

RSS
  • « Previous
  • 1...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...28
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites May 23, 2022
  • PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes April 27, 2022